Silexion Therapeutics shareholders raise authorized share capital via memorandum amendment
SLXN•Shareholders approve memorandum amendment
Silexion Therapeutics shareholders backed an amendment to its Cayman Islands memorandum, lifting authorized share capital.
The change was adopted at an extraordinary general meeting held July 13, 2026, then reconvened July 20, 2026.
The amendment took effect July 21, 2026, upon filing with the Cayman Islands Registrar of Companies.
